Inhibitory effect of snake venom toxin on NF-κB activity prevents human cervical cancer cell growth via increase of death receptor 3 and 5 expression
Authors:
- 23 November 2014
- journal article
- biologics
- Published by Springer Nature in Archives of Toxicology
- Vol. 90 (2) , 463-477
Abstract
We previously found that snake venom toxin inhibits nuclear factor kappa B (NF-κB) activity in several cancer cells. NF-κB is implicated in cancer cell growth and chemoresistance. In our present study, we investigated whether snake venom toxin (SVT) inhibits NF-κB, thereby preventing human cervical cancer cell growth (Ca Ski and C33A). SVT (0–12 μg/ml) inhibited the growth of cervical cancer cells by the induction of apoptotic cell death. These inhibitory effects were associated with the inhibition of NF-κB activity. However, SVT dose dependently increased the expression of death receptors (DRs): DR3, DR5 and DR downstream pro-apoptotic proteins. Exploration of NF-κB inhibitor (Phenylarsine oxide, 0.1 μM) synergistically further increased SVT-induced DR3 and DR5 expressions accompanied with further inhibition of cancer cells growth. Moreover, deletion of DR3 and DR5 by small interfering RNA significantly abolished SVT-induced cell growth inhibitory effects, as well as NF-κB inactivation. Using TNF-related apoptosis-inducing ligand resistance cancer cells (A549 and MCF-7), we also found that SVT enhanced the susceptibility of chemoresistance of these cancer cells through down-regulation of NF-κB, but up-regulation of DR3 and DR5. In vivo study also showed that SVT (0.5 and 1 mg/kg) inhibited tumor growth accompanied with inactivation of NF-κB. Thus, our present study indicates that SVT could be applicable as an anticancer agent for cervical cancer, or as an adjuvant agent for chemoresistant cancer cells.Keywords
This publication has 51 references indexed in Scilit:
- Targeting Death Receptor TRAIL-R2 by Chalcones for TRAIL-Induced Apoptosis in Cancer CellsInternational Journal of Molecular Sciences, 2012
- The adaptor protein FADD and the initiator caspase-8 mediate activation of NF-κB by TRAILCell Death & Disease, 2012
- Snake venom toxin from vipera lebetina turanicainduces apoptosis of colon cancer cells via upregulation of ROS- and JNK-mediated death receptor expressionBMC Cancer, 2012
- Fas death receptor signalling: roles of Bid and XIAPCell Death & Differentiation, 2011
- The NF-κB activation pathways, emerging molecular targets for cancer prevention and therapyExpert Opinion on Therapeutic Targets, 2009
- Fisetin, a natural flavonoid, targets chemoresistant human pancreatic cancer AsPC‐1 cells through DR3‐mediated inhibition of NF‐κBInternational Journal of Cancer, 2009
- NF-κB in carcinoma therapy and preventionExpert Opinion on Therapeutic Targets, 2008
- NF-κB and cancer — identifying targets and mechanismsCurrent Opinion in Genetics & Development, 2008
- Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesisMolecular Cancer, 2008
- The Death Domain Superfamily in Intracellular Signaling of Apoptosis and InflammationAnnual Review of Immunology, 2007